Onconetix Inc
ONCO
NASDAQ
Biotechnology
$0.81
USD
-0.07 (-8.06%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.48M
Volume 232.1K
Revenue
$735,198
TTM
-61.8%
YoY
Gross Margin
80%
TTM
+68.1%
YoY
Net Income
$-9.70M
TTM
+82.7%
YoY
Operating Cash Flow
$-9.80M
TTM
-34.9%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.1 | 0.1 | 0.3 | 0.3 | 0.0 |
YoY Growth | -85.5% | -84.9% | -25.4% | -57.4% | -78.9% |
Cost of Revenue | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 |
Gross Profit | 0.0 | 0.1 | 0.3 | 0.2 | -0.0 |
Selling, General & Administrative | 1.7 | 1.5 | 2.3 | 1.5 | 2.0 |
Other Operating Expenses | 10.9 | 0.6 | 0.0 | 0.0 | 8.1 |
Total Operating Expenses | 12.6 | 2.0 | 2.3 | 1.5 | 10.2 |
Operating Income | -12.6 | -1.9 | -2.1 | -1.3 | -10.2 |
EBITDA | -1.6 | -1.3 | -2.1 | -1.3 | -2.1 |
Other Income / Expense | 4.2 | -0.2 | -6.4 | 7.0 | 6.0 |
Total Other Income / Expense | 4.0 | -0.4 | -6.7 | 7.0 | 6.0 |
Income Before Income Taxes | -8.5 | -2.4 | -8.8 | 5.7 | -4.2 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -8.5 | -2.4 | -8.8 | 5.7 | -4.2 |
Consolidated Net Income / Loss | -8.5 | -2.4 | -8.8 | 5.7 | -4.2 |
Net Income Attributable to Common Shareholders | -9.7 | -2.7 | -8.8 | 5.7 | -4.2 |
Basic EPS | -$2,272.50 | -$238.00 | -$312.50 | $181.27 | -$67.10 |
Diluted EPS | -$2,272.50 | -$238.00 | -$312.50 | $181.27 | -$67.10 |
Basic Shares Outstanding | 0.0M | 0.0M | 0.0M | 0.0M | 0.1M |
Diluted Shares Outstanding | 0.0M | 0.0M | 0.0M | 0.0M | 0.1M |